Klotz, Laurence. 2012. “Sunitinib, Sorafenib and Other Systemic Noncytotoxic Kidney Cancer Therapies Can and Should Be Administered by Urologists”. Canadian Urological Association Journal 1 (2S). https://doi.org/10.5489/cuaj.70.